Literature DB >> 28453746

Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.

Changbin Zhu1,2, Dana Mustafa1, Ping-Pin Zheng1, Marcel van der Weiden1, Andrea Sacchetti1, Maarten Brandt3, Ihsan Chrifi3, Dennie Tempel4, Pieter J M Leenen5, Dirk Jan Duncker3, Caroline Cheng3,6, Johan M Kros1.   

Abstract

Background: The majority of glioma-associated microglia/macrophages have been identified as M2-type macrophages with immune suppressive and tumor supportive action. Recently, the extracellular adenosine deaminase protein Cat Eye Syndrome Critical Region Protein 1 (CECR1) was shown to regulate macrophage maturation. In this study, we investigate the role of CECR1 in the regulation of the glioma-associated macrophage response.
Methods: Expression of CECR1 was assessed in human glioma samples. CECR1-mediated macrophage response was studied in vitro, using donor derived CD14+ monocytes and the THP-1 monocytic cell line. The response of the human glioma cell line U87 to conditioned medium of macrophages preconditioned with recombinant human CECR1 or CECR1 silencing was also assessed.
Results: CECR1 was strongly expressed in high-grade gliomas (P < .001) and correlated positively with the M2 phenotype markers in tumor-associated microglia/macrophages (TAMs) (overall, P < .05). In vitro studies confirmed the presence of a significantly higher level of CECR1 expression in M2-like macrophages exposed to U87 conditioned medium (P < .001). CECR1 knockdown or stimulation of macrophages affected differentiation toward the M2-like phenotype. Stimulation of U87 cells with conditioned medium of CECR1 knockdown or stimulated macrophages affected tumor cell proliferation and migration, coinciding with altered intracellular signaling of mitogen-activated protein kinase (MAPK). In glioma tissue samples, CECR1 expression correlated with Ki67 and MAPK signaling protein. Conclusions: CECR1 is a potent regulator of TAM polarization and is consistently highly expressed by M2-type TAMs, particularly in high-grade glioma. Paracrine effects induced by CECR1 in M2-like TAMs activate MAPK signaling and stimulate the proliferation and migration of glioma cells.
© The Author(s) 2017. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  CECR1; glioblastoma; glioma; tumor associated macrophages (TAMs)

Mesh:

Substances:

Year:  2017        PMID: 28453746      PMCID: PMC5464467          DOI: 10.1093/neuonc/now251

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  39 in total

Review 1.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

Authors:  Tomás Alvaro; Marylène Lejeune; Francisca I Camacho; Ma Teresa Salvadó; Lydia Sánchez; Juan F García; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons; Carmen Bellas; Miguel A Piris
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

3.  New insights into the regulation of inflammation by adenosine.

Authors:  Joel Linden
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization.

Authors:  Min-Min Chen; Xiao Xiao; Xiang-Ming Lao; Yuan Wei; Rui-Xian Liu; Qiu-Hui Zeng; Jun-Cheng Wang; Fang-Zhu Ouyang; Dong-Ping Chen; Ka-Wo Chan; Dai-Chao Shi; Limin Zheng; Dong-Ming Kuang
Journal:  Cancer Discov       Date:  2016-08-16       Impact factor: 39.397

5.  Flt-1 signaling in macrophages promotes glioma growth in vivo.

Authors:  Mark Kerber; Yvonne Reiss; Anke Wickersheim; Manfred Jugold; Fabian Kiessling; Matthias Heil; Vadim Tchaikovski; Johannes Waltenberger; Masabumi Shibuya; Karl H Plate; Marcia Regina Machein
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

6.  Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire.

Authors:  Jennifer S Sims; Boris Grinshpun; Yaping Feng; Timothy H Ung; Justin A Neira; Jorge L Samanamud; Peter Canoll; Yufeng Shen; Peter A Sims; Jeffrey N Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-03       Impact factor: 11.205

7.  The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling.

Authors:  Christopher James Ferrante; Grace Pinhal-Enfield; Genie Elson; Bruce Neil Cronstein; Gyorgy Hasko; Shalini Outram; Samuel Joseph Leibovich
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

8.  Tumor induction of VEGF promoter activity in stromal cells.

Authors:  D Fukumura; R Xavier; T Sugiura; Y Chen; E C Park; N Lu; M Selig; G Nielsen; T Taksir; R K Jain; B Seed
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

9.  Human breast cancer cells educate macrophages toward the M2 activation status.

Authors:  Sofia Sousa; Régis Brion; Minnamaija Lintunen; Pauliina Kronqvist; Jouko Sandholm; Jukka Mönkkönen; Pirkko-Liisa Kellokumpu-Lehtinen; Susanna Lauttia; Olli Tynninen; Heikki Joensuu; Dominique Heymann; Jorma A Määttä
Journal:  Breast Cancer Res       Date:  2015-08-05       Impact factor: 6.466

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  25 in total

Review 1.  CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges.

Authors:  Stephen J Bagley; Arati S Desai; Gerald P Linette; Carl H June; Donald M O'Rourke
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

Review 2.  Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Authors:  Depeng Yang; Lijun Yang; Jialing Cai; Huaxin Li; Zheng Xing; Ying Hou
Journal:  Mol Cell Biochem       Date:  2022-05-19       Impact factor: 3.842

3.  A novel DNA damage and repair-related gene signature to improve predictive capacity of overall survival for patients with gliomas.

Authors:  Xiaodong Li; Yichang Wang; Wei Wu; Jianyang Xiang; Maode Wang; Hai Yu
Journal:  J Cell Mol Med       Date:  2022-05-26       Impact factor: 5.295

Review 4.  Glioma-Associated Microglia Characterization in the Glioblastoma Microenvironment through a 'Seed-and Soil' Approach: A Systematic Review.

Authors:  Grazia Menna; Pier Paolo Mattogno; Carlo Maria Donzelli; Lucia Lisi; Alessandro Olivi; Giuseppe Maria Della Pepa
Journal:  Brain Sci       Date:  2022-05-31

Review 5.  Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells.

Authors:  Xiaojin Liu; Yuan Liu; Yiwei Qi; Yimin Huang; Feng Hu; Fangyong Dong; Kai Shu; Ting Lei
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

Review 6.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

Review 7.  A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression.

Authors:  Victor Delprat; Carine Michiels
Journal:  Cancer Metastasis Rev       Date:  2021-03-30       Impact factor: 9.264

8.  PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.

Authors:  Ran Xu; Jianxiong Ji; Xin Zhang; Mingzhi Han; Chao Zhang; Yangyang Xu; Yuzhen Wei; Shuai Wang; Bin Huang; Anjing Chen; Di Zhang; Qing Zhang; Wenjie Li; Zheng Jiang; Jian Wang; Xingang Li
Journal:  J Exp Clin Cancer Res       Date:  2017-12-28

Review 9.  Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.

Authors:  Jun Ma; Clark C Chen; Ming Li
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.

Authors:  Jin-Zhang Sun; Jin-Hao Zhang; Jia-Bo Li; Feng Yuan; Lu-Qing Tong; Xu-Ya Wang; Lu-Lu Chen; Xiao-Guang Fan; Yi-Ming Zhang; Xiao Ren; Chen Zhang; Sheng-Ping Yu; Xue-Jun Yang
Journal:  Dis Markers       Date:  2021-06-09       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.